BAP1 and pancreatic neoplasm: The Australian Pancreatic Cancer Genome Initiative, the International Cancer Genome Consortium, and several other studies, who have performed whole exome and genome sequencing on a number of PDAC specimens have yet to locate any BAP1 mutations or deletions in PDAC [4,30–32], which closely conforms with the results of this research.